Amneal Pharmaceuticals, Inc Class A Common Stock Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$722,519	$814,319	$784,513	$724,508
Gross Profit	320,113	297,190	273,974	286,253
EBITDA	176,728	160,699	111,664	176,925
EBIT	133,537	111,472	57,591	116,812
Net Income	62,497	35,076	2,369	22,417
Net Change In Cash	722,519	814,319	784,513	724,508
Free Cash Flow		87,146	103,400	57,317
Cash	197,656	310,871	201,249	81,186
Basic Shares	328,933	324,805	324,754	322,363

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,018,760	$2,793,957	$2,393,607	$2,212,304
Gross Profit	1,136,092	1,020,438	863,869	791,461
EBITDA	603,872	439,773	500,782	440,208
EBIT	380,300	203,582	271,382	200,033
Net Income	72,057	-116,886	-83,993	-129,985
Net Change In Cash	3,018,760	2,793,957	2,393,607	2,212,304
Cost of Revenue				-215,829
Free Cash Flow	269,929	220,109	276,388	-25,495
Cash	310,871	110,552	91,542	25,976
Basic Shares	324,805	308,978	176,136	150,944